TradingKey

Más Datos de IDEXX Laboratories Inc Compañía

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.

Información de la empresa

Símbolo de cotizaciónIDXX

Nombre de la empresaIDEXX Laboratories Inc

Fecha de salida a bolsaJun 21, 1991

Director ejecutivoMr. Andrew Emerson

Número de empleados11000

Tipo de seguridadOrdinary Share

Fin del año fiscalJun 21

DirecciónOne Idexx Drive

CiudadWESTBROOK

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal04092-2041

Teléfono12075560300

Sitio Webhttps://www.idexx.com/

Símbolo de cotizaciónIDXX

Fecha de salida a bolsaJun 21, 1991

Director ejecutivoMr. Andrew Emerson

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+9.56%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

Dr. Stuart M. Essig, Ph.D.

Independent Director

1.09K

+31.76%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

CAG Diagnostics recurring revenue

806.27M

80.75%

IDEXX VetLab consumables

344.78M

34.53%

Reference laboratory diagnostic and consulting services

344.41M

34.49%

Rapid assay products

84.03M

8.42%

Veterinary software, services and diagnostic imaging systems

81.58M

8.17%

Otro

-662.63M

-66.37%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

654.86M

65.59%

Europe & Middle East & Africa (EMEA) (Region)

204.55M

20.49%

Asia Pacific

81.73M

8.19%

Canada

37.30M

3.74%

Latin America

19.99M

2.00%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

CAG Diagnostics recurring revenue

806.27M

80.75%

IDEXX VetLab consumables

344.78M

34.53%

Reference laboratory diagnostic and consulting services

344.41M

34.49%

Rapid assay products

84.03M

8.42%

Veterinary software, services and diagnostic imaging systems

81.58M

8.17%

Otro

-662.63M

-66.37%

Estadísticas de accionistas

Actualizado: mar., 19 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Global Advisors (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

Otro

70.25%

Accionistas

Proporción

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Global Advisors (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

Otro

70.25%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

54.31%

Investment Advisor/Hedge Fund

32.80%

Research Firm

3.95%

Pension Fund

2.29%

Bank and Trust

2.06%

Hedge Fund

0.93%

Individual Investor

0.69%

Sovereign Wealth Fund

0.61%

Family Office

0.54%

Otro

1.83%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

2023Q1

2158

77.14M

92.96%

-2.07M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

9.82M

12.21%

+146.37K

+1.51%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

5.44M

6.76%

+113.70K

+2.14%

Mar 31, 2025

State Street Global Advisors (US)

3.65M

4.54%

+12.32K

+0.34%

Mar 31, 2025

Fundsmith LLP

2.65M

3.29%

-14.52K

-0.55%

Mar 31, 2025

Geode Capital Management, L.L.C.

2.41M

3%

+112.62K

+4.90%

Mar 31, 2025

Baron Capital Management, Inc.

2.06M

2.56%

+54.26K

+2.71%

Mar 31, 2025

Invesco Capital Management (QQQ Trust)

1.66M

2.07%

-25.31K

-1.50%

Jun 30, 2025

Principal Global Investors (Equity)

1.13M

1.4%

+414.80K

+58.32%

Mar 31, 2025

William Blair & Company, L.L.C. (Research)

1.09M

1.36%

-14.24K

-1.29%

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 6 de sep

Nombre

Proporción

ProShares Pet Care ETF

10.39%

First Trust Water ETF

5.65%

iShares U.S. Medical Devices ETF

5.62%

Nuveen ESG Mid-Cap Growth ETF

3.56%

Simplify Next Intangible Core Index ETF

3.22%

Hennessy Sustainable ETF

3.19%

Adaptive Core ETF

2.75%

Janus Henderson Mid Cap Growth Alpha ETF

2.63%

Invesco Raymond James SB-1 Equity ETF

2.52%

First Trust S&P 500 Economic Moat Index ETF

2.42%

ProShares Pet Care ETF

Proporción10.39%

First Trust Water ETF

Proporción5.65%

iShares U.S. Medical Devices ETF

Proporción5.62%

Nuveen ESG Mid-Cap Growth ETF

Proporción3.56%

Simplify Next Intangible Core Index ETF

Proporción3.22%

Hennessy Sustainable ETF

Proporción3.19%

Adaptive Core ETF

Proporción2.75%

Janus Henderson Mid Cap Growth Alpha ETF

Proporción2.63%

Invesco Raymond James SB-1 Equity ETF

Proporción2.52%

First Trust S&P 500 Economic Moat Index ETF

Proporción2.42%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

IDEXX Laboratories Inc

643.990USD

IDEXX Laboratories Inc

643.990

Descripción general

Compañía

Finanzas

Análisis